Non-traditional risk factors of progression of chronic kidney disease in adult population: a scoping review
暂无分享,去创建一个
E. Sierra-Diaz | Elena Sandoval-Pinto | R. Cremades | A. Ramírez-de-Arellano | Mariana García-Gutiérrez | Diana Lorena Cisneros-García | Roberto Martínez-de-Pinillos-Valverde
[1] Erick Sierra-Díaz,et al. Incidencia de fiebre y hemorragia post nefrolitotomía percutánea: un estudio de cohorte prospectivo , 2022, Cirugía y Cirujanos.
[2] M. Bots,et al. End-stage kidney disease in patients with clinically manifest vascular disease; incidence and risk factors: results from the UCC-SMART cohort study , 2021, Journal of Nephrology.
[3] R. Reyes-Acevedo,et al. High prevalence of end-stage renal disease of unknown origin in Aguascalientes Mexico: role of the registry of chronic kidney disease and renal biopsy in its approach and future directions , 2021, Clinical kidney journal.
[4] Jenny I. Shen,et al. The Case for Early Identification and Intervention of Chronic Kidney Disease: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. , 2020, Kidney international.
[5] L. Gesualdo,et al. Recurrent Glomerulonephritis after Renal Transplantation: The Clinical Problem , 2020, International journal of molecular sciences.
[6] D. Henriksen,et al. Second-generation antipsychotics and the risk of chronic kidney disease: a population-based case-control study , 2020, BMJ Open.
[7] A. Garg,et al. Association of Early Postdonation Renal Function With Subsequent Risk of End-Stage Renal Disease in Living Kidney Donors. , 2020, JAMA surgery.
[8] D. Şelimen,et al. Investigation of the Causes and Risk Factors of Previous End-Stage Renal Disease in Kidney Transplant Recipients. , 2019, Transplantation proceedings.
[9] Nasser A. Polanco-Flores. Chronic renal disease in Mexico: A preventive uncontrolled epidemic , 2019, Revista M�dica del Hospital General de M�xico.
[10] Y. Khader,et al. Risk Factors for End-Stage Renal Failure Among Patients on Hemodialysis in Aljomhory Hospital, Sa’adah Governorate, Yemen: Hospital-Based Case-Control Study , 2019, JMIR public health and surveillance.
[11] O. Adejumo,et al. Burden, psychological well-being and quality of life of caregivers of end stage renal disease patients , 2019, Ghana medical journal.
[12] H. Choi,et al. The risk of end-stage renal disease in systemic lupus erythematosus , 2019, Medicine.
[13] Raj Munshi,et al. Benefits and risks of protocol biopsies in pediatric renal transplantation , 2019, Pediatric Nephrology.
[14] P. Stenvinkel,et al. Chronic inflammation in end-stage renal disease and dialysis , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[15] V. Tesar,et al. Mutational screening of inverted formin 2 in adult-onset focal segmental glomerulosclerosis or minimal change patients from the Czech Republic , 2018, BMC Medical Genetics.
[16] Rajeev Sharma,et al. Utility of Serial Protocol Biopsies Performed After 1 Year in Predicting Long-Term Kidney Allograft Function According to Histologic Phenotype. , 2018, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation.
[17] G. García-García,et al. The Tragedy of Having ESRD in Mexico , 2018, Kidney international reports.
[18] L. Dello Strologo,et al. Protocol biopsies in pediatric renal transplantation: a precious tool for clinical management , 2018, Pediatric Nephrology.
[19] E. Sierra-Diaz,et al. Exposure to Radioactive Emanations of Medical Personnel in Percutaneous Nephrolithotomy , 2018, Dose-response : a publication of International Hormesis Society.
[20] M. Pontes,et al. Prevalence of clinically validated primary causes of end-stage renal disease (ESRD) in a State Capital in Northeastern Brazil , 2018, Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia.
[21] Marcello Tonelli,et al. The global burden of kidney disease and the sustainable development goals , 2018, Bulletin of the World Health Organization.
[22] E. Sierra-Diaz,et al. Prevalence of Albuminuria in Children Living in a Rural Agricultural and Fishing Subsistence Community in Lake Chapala, Mexico , 2017, International journal of environmental research and public health.
[23] F. Kronenberg,et al. Associations between genetic risk variants for kidney diseases and kidney disease etiology , 2017, Scientific Reports.
[24] F. Kronenberg,et al. Associations between genetic risk variants for kidney diseases and kidney disease etiology , 2017, Scientific Reports.
[25] C. Lewis,et al. Obesity increases the risk of end-stage renal disease among living kidney donors. , 2017, Kidney international.
[26] Ashutosh Kumar Singh,et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2016, The Lancet.
[27] Ashutosh Kumar Singh,et al. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2016, Lancet.
[28] M. Pavkovic,et al. Environmental exposure to arsenic and chromium in children is associated with kidney injury molecule-1. , 2016, Environmental research.
[29] T. Hussain,et al. Risk Factors of End Stage Renal Disease in Peshawar, Pakistan: Odds Ratio Analysis , 2016, Open access Macedonian journal of medical sciences.
[30] L. Plantinga,et al. Association of age with health-related quality of life in a cohort of patients with systemic lupus erythematosus: the Georgians Organized Against Lupus study , 2016, Lupus Science & Medicine.
[31] D. Richardson,et al. Pesticide exposure and end-stage renal disease risk among wives of pesticide applicators in the Agricultural Health Study. , 2015, Environmental research.
[32] K. Elmusharaf,et al. Causes of end stage renal failure among haemodialysis patients in Khartoum State/Sudan , 2015, BMC Research Notes.
[33] G. Nagel,et al. Sex- and Time-Dependent Patterns in Risk Factors of End-Stage Renal Disease: A Large Austrian Cohort with up to 20 Years of Follow-Up , 2015, PloS one.
[34] S. Navaneethan,et al. Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease , 2015, American Journal of Nephrology.
[35] G. Trifirò,et al. Association of Individual Non-Steroidal Anti-Inflammatory Drugs and Chronic Kidney Disease: A Population-Based Case Control Study , 2015, PloS one.
[36] Luxia Zhang,et al. Status of non‐steroidal anti‐inflammatory drugs use and its association with chronic kidney disease: A cross‐sectional survey in China , 2014, Nephrology.
[37] Paul Komenda,et al. Cost-effectiveness of primary screening for CKD: a systematic review. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[38] L. Boulware,et al. Disparities in the burden, outcomes, and care of chronic kidney disease , 2014, Current opinion in nephrology and hypertension.
[39] J. Sommar,et al. End-stage renal disease and low level exposure to lead, cadmium and mercury; a population-based, prospective nested case-referent study in Sweden , 2013, Environmental Health.
[40] A. Matas,et al. Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody‐Mediated Rejection and Nonadherence , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[41] N. Breslow,et al. Risk factors for end stage renal disease in non-WT1-syndromic Wilms tumor. , 2011, The Journal of urology.
[42] J. Boavida,et al. Prevalence of Chronic Kidney Disease and Associated Risk Factors, and Risk of End-Stage Renal Disease: Data from the PREVADIAB Study , 2011, Nephron Clinical Practice.
[43] Mohamed Elsharif,et al. Causes of end-stage renal disease in Sudan: a single-center experience. , 2011, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.
[44] Chun-Yuh Yang,et al. Analgesic use and the risk for progression of chronic kidney disease , 2010, Pharmacoepidemiology and drug safety.
[45] A K Mathur,et al. Geographic Variation in End‐Stage Renal Disease Incidence and Access to Deceased Donor Kidney Transplantation , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[46] V. Salomaa,et al. Risk factors for end‐stage renal disease in a community‐based population: 26‐year follow‐up of 25 821 men and women in eastern Finland , 2009, Journal of internal medicine.
[47] S. Haghpanah,et al. Causes of chronic renal failure among Iranian hemodialysis patients. , 2009, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.
[48] C. McCulloch,et al. Risk factors for end-stage renal disease: 25-year follow-up. , 2009, Archives of internal medicine.
[49] J. Góngora-Ortega,et al. Prevalencia de enfermedad renal crónica en niños de Aguascalientes, México , 2008 .
[50] A. Bello,et al. Socioeconomic status and chronic kidney disease at presentation to a renal service in the United Kingdom. , 2008, Clinical journal of the American Society of Nephrology : CJASN.
[51] S. Sindel,et al. Quality of life in hemodialysis, peritoneal dialysis, and transplantation patients. , 2007, Transplantation proceedings.
[52] F. Galli. Protein damage and inflammation in uraemia and dialysis patients. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[53] M. Tonelli,et al. NSAID use and progression of chronic kidney disease. , 2007, The American journal of medicine.
[54] S. Lipsitz,et al. Geographical patterns of end-stage renal disease incidence and risk factors in rural and urban areas of South Carolina. , 2007, Health & place.
[55] Carlos Iribarren,et al. Body Mass Index and Risk for End-Stage Renal Disease , 2006, Annals of Internal Medicine.
[56] X. Vidal,et al. Case-control study of regular analgesic and nonsteroidal anti-inflammatory use and end-stage renal disease. , 2005, Kidney international.
[57] W. Hörl,et al. Protocol biopsies after kidney transplantation , 2005, Transplant international : official journal of the European Society for Organ Transplantation.
[58] H. Arksey,et al. Scoping studies: towards a methodological framework , 2005 .
[59] T. Harrer,et al. Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus , 2002, Annals of the rheumatic diseases.
[60] P. Whelton,et al. Recreational drug use: a neglected risk factor for end-stage renal disease. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[61] J. Lv,et al. Prevalence and Disease Burden of Chronic Kidney Disease. , 2019, Advances in experimental medicine and biology.
[62] A. Ruiz-Martinez,et al. Renal Doppler ultrasound resistive index vs. renal scintigraphy with 99mTc-DTPA as diagnostic test for ureteropelvic junction obstruction in children. , 2019, Actas urologicas espanolas.
[63] A. Matamala,et al. MYH9 Associated nephropathy. , 2018, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.
[64] M. Jankowska,et al. Inflammation and Protein-Energy Wasting in the Uremic Milieu. , 2017, Contributions to nephrology.
[65] G. García-García,et al. Burden of end-stage renal disease (ESRD) in Latin America. , 2016, Clinical nephrology.
[66] Brenda R. Hemmelgarn,et al. Notice , 2012, Kidney International Supplements.
[67] P. Kimmel,et al. Quality of life in patients with chronic kidney disease: focus on end-stage renal disease treated with hemodialysis. , 2006, Seminars in nephrology.
[68] A. Collins,et al. Differences between blacks and whites in the incidence of end-stage renal disease and associated risk factors. , 2004, Advances in renal replacement therapy.